Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 5/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 2/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.37 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.37 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL3628164 | 0.96 | SLC1A1 (0.41) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| Serine SCHEMBL12500509 | 0.96 | SLC1A1 (0.41) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| Serine SCHEMBL17792546 | 0.89 | SLC1A1 (0.47) | SLC1A1GSRGRIK1SLC1A3SLC1A2 | |
| Asparagine SCHEMBL7563049 | 0.89 | SLC1A1 (0.40) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| Serine SCHEMBL15094110 | 0.86 | SLC1A5 (0.38) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| Serine SCHEMBL3052910 | 0.86 | SLC1A5 (0.35) | SLC1A1PTGS1SLC7A11GSR | |
| Serine SCHEMBL3821533 | 0.86 | SLC1A5 (0.38) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| Serine SCHEMBL6568300 | 0.86 | SLC1A1 (0.34) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| SCHEMBL1072689 | 0.85 | SLC1A5 (0.36) | SLC1A1PTGS1SLC7A11GSRGRIK1 | |
| Serine SCHEMBL6666261 | 0.85 | SLC7A5 (0.38) | SLC1A1PTGS1SLC7A11GSRGRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4355886-A1 | RETINAL DISORDERS | Ikarovec Limited (GB) | 2024-04-24 | — | — | EP | claimed |
| EP-4355767-A1 | RETINAL DISORDERS | Ikarovec Limited (GB) | 2024-04-24 | — | — | EP | claimed |
| EP-4355789-A2 | TNFSF-L FUSION PROTEINS AND USES THEREOF | KaliVir Immunotherapeutics, Inc. (US) | 2024-04-24 | — | — | EP | claimed |
| EP-3283124-B1 | BIOCONJUGATES AND USES THEREOF | SYMIC HOLDINGS USA INC (US) | 2024-04-24 | — | — | EP | claimed |
| CN-117916274-A | TNFSF-L fusion proteins and uses thereof | 卡利威尔免疫治疗公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117897493-A | Retinal disorders | 伊卡罗维克有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117813321-A | Retinal disorders | 伊卡罗维克有限公司 | 2024-04-02 | — | — | CN | claimed |
| EP-4151647-A1 | AMINO ACID SEQUENCE OF RECOMBINANT TICK-BORNE ENCEPHALITIS VIRUS-LIKE PARTICLES AND THEIR USE AS A VACCINE ANTIGEN FOR PREVENTION OF TICK-BORNE ENCEPHALITIS VIRUS INFECTIONS | University of Gdansk (PL) | 2023-03-22 | — | — | EP | claimed |
| WO-2022263841-A1 | RETINAL DISORDERS | Ikarovec Limited (GB) | 2022-12-22 | — | — | WO | claimed |
| WO-2022266163-A2 | TNFSF-L FUSION PROTEINS AND USES THEREOF | KALIVIR IMMUNOTHERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | claimed |
| WO-2019010490-A1 | BICONJUGATES WITH CHEMICALLY MODIFIED BACKBONES | SYMIC IP, LLC (US) | 2019-01-10 | — | — | WO | claimed |
| CN-107771085-A | Bioconjugates and application thereof | 斯米克IP有限公司 | 2018-03-06 | — | — | CN | claimed |
| EP-3283124-A1 | BIOCONJUGATES AND USES THEREOF | Symic IP, LLC (US) | 2018-02-21 | — | — | EP | claimed |
| WO-2017132332-A1 | CHIMERIC HEPATITIS D VIRUS ANTIGEN AND HEPATITIS B VIRUS PRE S1 GENES FOR USE ALONE OR IN VACCINES CONTANING HEPATITIS B VIRUS GENES | SVENSKA VACCINFABRIKEN PRODUKTION AB (SE) | 2017-08-03 | — | — | WO | claimed |
| US-20170112941-A1 | VE-CADHERIN BINDING BIOCONJUGATE | SYMIC IP, LLC | 2017-04-27 | — | — | US | claimed |
| US-20160331841-A1 | BIOCONJUGATES AND USES THEREOF | SYMIC IP, LLC | 2016-11-17 | — | — | US | claimed |
| WO-2016168743-A1 | BIOCONJUGATES AND USES THEREOF | SYMIC IP, LLC (US) | 2016-10-20 | — | — | WO | claimed |
| US-20160228531-A1 | TREATMENT OF HEPATITIS D VIRUS INFECTIONS BY REDIRECTION OF T CELLS | CHRONTECH PHARMA AB (SE) | 2016-08-11 | — | — | US | claimed |
| EP-3046936-A1 | TREATMENT OF HEPATITIS D VIRUS INFECTIONS BY REDIRECTION OF T CELLS | ChronTech Pharma AB (SE) | 2016-07-27 | — | — | EP | claimed |
| WO-2015042187-A1 | TREATMENT OF HEPATITIS D VIRUS INFECTIONS BY REDIRECTION OF T CELLS | CHRONTECH PHARMA AB (SE) | 2015-03-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331841-A1 | BIOCONJUGATES AND USES THEREOF | CD44, VCAM1, ICAM1 | SLC1A1 1192/4885PTGS1 2460/4885SLC7A11 789/4885 |
| US-20170112941-A1 | VE-CADHERIN BINDING BIOCONJUGATE | EPCAM, CDH1, VCAM1 | SLC1A1 1342/4885PTGS1 4543/4885SLC7A11 1066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.